CorMedix Inc. (CRMD)
CorMedix Statistics
Share Statistics
CorMedix has 67.82M shares outstanding. The number of shares has increased by 10.4% in one year.
| 67.82M |
| 10.4% |
| 0% |
| 39.02% |
| n/a |
| 17,463 |
| 0.91% |
Short Selling Information
The latest short interest is 8.45M, so 12.46% of the outstanding shares have been sold short.
| 8.45M |
| 12.46% |
| 12.6% |
| 2.77 |
Valuation Ratios
The PE ratio is -26.6 and the forward PE ratio is 8.74. CorMedix's PEG ratio is 0.4.
| -26.6 |
| 8.74 |
| 10.97 |
| 3 |
| 0.01 |
| -9.4 |
| 0.4 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CorMedix.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
| 0 |
| 0 |
| 0 |
| -0.03 |
| -0.01 |
| -614.1 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $679,252.66 |
| $-280,156.56 |
| 64 |
| 0.37 |
| 0.42 |
Taxes
| -1.39M |
| 7.22% |
Stock Price Statistics
The stock price has increased by 170.93% in the last 52 weeks. The beta is 1.61, so CorMedix's price volatility has been higher than the market average.
| 1.61 |
| 170.93% |
| 9.77 |
| 9.59 |
| 74.53 |
| 1,912,885 |
Income Statement
In the last 12 months, CorMedix had revenue of 43.47M and earned -17.93M in profits. Earnings per share was -0.3.
| 43.47M |
| 40.28M |
| -22.36M |
| -17.93M |
| -18.83M |
| -19.29M |
| -0.3 |
Balance Sheet
The company has 40.65M in cash and 517.01K in debt, giving a net cash position of 40.13M.
| 40.65M |
| 517.01K |
| 40.13M |
| -339.63B |
| 149.58M |
| 110.47M |
Cash Flow
In the last 12 months, operating cash flow was -50.61M and capital expenditures -115.73K, giving a free cash flow of -50.73M.
| -50.61M |
| -115.73K |
| -50.73M |
| -0.86 |
Margins
Gross margin is 92.66%, with operating and profit margins of -51.43% and -41.24%.
| 92.66% |
| -51.43% |
| -44.45% |
| -41.24% |
| -43.32% |
| -51.43% |
| -116.7% |
Dividends & Yields
CRMD does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CRMD is $15, which is 7.3% higher than the current price. The consensus rating is "Buy".
| $15 |
| 7.3% |
| Buy |
| 6 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Mar 26, 2019. It was a backward split with a ratio of 1:5.
| Mar 26, 2019 |
| backward |
| 1:5 |
Scores
| 13.42 |
| 4 |